Researchers estimate cancer risk in patients with pancreatic cysts, advancing early detection
Mayo Clinic researchers have estimated the risk that pancreatic cysts with worrisome or high-risk features will progress to pancreatic cancer or advanced precancerous changes within three years. The findings, published in Gastroenterology, could help physicians and patients better assess risk and make more informed decisions about whether to monitor a cyst or consider surgery.
Mayo Clinic researchers have estimated the likelihood of pancreatic cysts progressing to cancer within three years. Their findings, published in Gastroenterology, aim to assist physicians and patients in making more informed decisions about monitoring or surgery. Risk increased with the number of worrisome features, with patients having one feature facing a 2% chance, two features a 4% chance, and three or more features an 18% chance of developing pancreatic cancer or advanced precancerous changes.
This information helps counsel patients about the potential need for early detection or avoiding unnecessary interventions.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
